Comparative dosimetric analysis of the whole brain, dural venous sinuses and skull bone marrow as candidate organs at risk for treatment-related lymphopenia in glioblastoma

Clicks: 5
ID: 337876
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #31 of 33 articles by views in journal of radiation research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Treatment-related lymphopenia is an established prognostic factor in glioblastoma, yet the anatomical origin remains unclear. This retrospective single-center study compared the whole brain, dural venous sinus and cranial bone marrow as organs at risk for predicting lymphocyte depletion and evaluated the prognostic significance of nadir absolute lymphocyte count (ALC). The cohort comprised 155 patients with IDH-wildtype glioblastoma treated with concurrent chemoradiotherapy. V20 Gy was extracted for each structure. Cox proportional hazards regression evaluated associations between nadir ALC and overall survival. Multiple linear regression predicted nadir ALC from dosimetric parameters adjusted for clinical factors and regimen. Nadir ALC independently predicted overall survival (HR 0.897 per 100 cells/μl; P = 0.004), and severe lymphopenia (ALC < 500 cells/μl) was associated with shorter median overall survival (15.1 vs 21.1 months; P = 0.012). Whole brain and skull V20 Gy were each significantly associated with nadir ALC (both P < 0.01), whereas dural venous sinuses V20 Gy was not (P = 0.194). Brain and skull models showed equivalent predictive performance (AIC 185 vs 184, R2 0.351 vs 0.353). The two doses were strongly correlated (Spearman ρ = 0.925), and neither remained significant when entered simultaneously, so the responsible structure cannot be determined. In regimen-stratified analyses, both structures remained significant in the 40 Gy cohort, but not in the 60 Gy cohort. Cranial bone marrow dose predicts nadir ALC comparably to, but inseparably from, whole brain dose, and nadir ALC is independently prognostic for survival. These hypothesis-generating findings require validation before adopting skull-sparing strategies in glioblastoma radiotherapy.
Reference Key
openalex_W7225013842 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Akihito Okubo, Shigeyuki Takamatsu, Kenta Nishimura, Risako Minamikawa, Takayuki Sakurai, Toshiya Ichinose, Masashi Kinoshita, Mitsutoshi Nakada, Satoshi Kobayashi
Are you one of these authors? Claim your profile
Journal journal of radiation research
Year 2026
DOI
10.1093/jrr/rrag096
URL
https://doi.org/10.1093/jrr/rrag096
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.